ANDO; Haruhi

Patent Applications and Registrations

Patent applications and USPTO patent grants for ANDO; Haruhi.The latest application filed is for "condensed-cyclic compound".

Company Profile

7.16.16

ANDO; Haruhi - Kanagawa JP
Ando; Haruhi - Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Condensed-cyclic Compound App 20220041581 - SASAKI; Shinobu ; et al.	2022-02-10
Heterocyclic compound Grant 11,236,099 - Takami , et al. February 1, 2	2022-02-01
Heterocyclic Compound App 20220017530 - Takami; Kazuaki ; et al.	2022-01-20
Heterocyclic Compound App 20210380565 - SASAKI; Shinobu ; et al.	2021-12-09
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 11,174,272 - Koike , et al. November 16, 2	2021-11-16
Heterocyclic Compounds Useful As Modulators Of Acetylcholine Receptors App 20210292308 - SASAKI; Shinobu ; et al.	2021-09-23
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20210206781 - KOIKE; Tatsuki ; et al.	2021-07-08
Heterocyclic Compound App 20210139491 - TAKAMI; Kazuaki ; et al.	2021-05-13
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,717,748 - Koike , et al.	2020-07-21
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20200157117 - KOIKE; Tatsuki ; et al.	2020-05-21
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,550,129 - Koike , et al. Fe	2020-02-04
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20190233436 - KOIKE; Tatsuki ; et al.	2019-08-01
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,273,245 - Koike , et al.	2019-04-30
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20190071455 - KOIKE; Tatsuki ; et al.	2019-03-07
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 10,144,743 - Koike , et al. De	2018-12-04
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20170145031 - KOIKE; Tatsuki ; et al.	2017-05-25
Heterocyclic compound Grant 9,624,184 - Koike , et al. April 18, 2	2017-04-18
Heterocyclic compound Grant 9,598,398 - Koike , et al. March 21, 2	2017-03-21
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,586,930 - Koike , et al. March 7, 2	2017-03-07
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20160326136 - KOIKE; Tatsuki ; et al.	2016-11-10
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,440,990 - Koike , et al. September 13, 2	2016-09-13
Heterocyclic compound Grant 9,296,746 - Koike , et al. March 29, 2	2016-03-29
Heterocyclic Compound App 20160052897 - KOIKE; Tatsuki ; et al.	2016-02-25
Heterocyclic Compound App 20160024049 - KOIKE; Tatsuki ; et al.	2016-01-28
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20150376205 - KOIKE; Tatsuki ; et al.	2015-12-31
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases Grant 9,193,709 - Koike , et al. November 24, 2	2015-11-24
Heterocyclic Compound App 20150266872 - Koike; Tatsuki ; et al.	2015-09-24
Fused heterocyclic compounds Grant 8,940,758 - Taniguchi , et al. January 27, 2	2015-01-27
Heterocyclic compounds Grant 8,871,766 - Koike , et al. October 28, 2	2014-10-28
Heterocyclic compounds Grant 8,865,717 - Koike , et al. October 21, 2	2014-10-21
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases App 20140228373 - Koike; Tatsuki ; et al.	2014-08-14
Heterocyclic compounds Grant 8,648,079 - Koike , et al. February 11, 2	2014-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.